Roswell Park Cancer Institute
Research / Science organisation
Location:
Buffalo, NY,
United States (USA) (US)
ISNI: 0000000121818635
ROR: https://ror.org/0499dwk57
Show on Map:
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014)
Koebel M, Madore J, Ramus SJ, Clarke BA, Pharoah PDP, Deen S, Bowtell DD, et al.
Journal article
MicroRNA Related Polymorphisms and Breast Cancer Risk (2014)
Khan S, Greco D, Michailidou K, Milne RL, Muranen TA, Heikkinen T, Aaltonen K, et al.
Journal article
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk (2014)
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, Mcguire V, Rossing MA, et al.
Journal article
Circulating miR-148b and miR-133a as biomarkers for breast cancer detection (2014)
Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, et al.
Journal article
Risk of Ovarian Cancer and the NF-?B Pathway: Genetic Association with IL1A and TNFSF10 (2014)
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, et al.
Journal article
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer (2013)
Pharoah PDP, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, et al.
Journal article